Trigg Leslie
Chair and CEO
Trigg Leslie has filed 8 SEC Form 4 filings (10 transaction rows) across 2 companies, including OM, EXAS, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Trigg Leslie is listed as Chair and CEO at Outset Medical, Inc. Inside the rolling window, Trigg Leslie reported no open-market purchases and 7 open-market sales totaling $122K in OM. The largest disclosed transaction in the window is a sale of 11,794 OM shares on Jan 20, 2026, worth $60K.
Companies traded
Other insiders at OM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$122K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Trigg Leslie made?
Trigg Leslie has filed 8 SEC Form 4 filings (10 transaction rows) across 2 companies, including OM, EXAS since 2025.
Which companies does Trigg Leslie trade?
Trigg Leslie has filed SEC Form 4 disclosures for 2 companies, including OM, EXAS.
When was Trigg Leslie's most recent SEC Form 4 filing?
Trigg Leslie's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Trigg Leslie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Trigg Leslie is listed as Chair and CEO.
What is Trigg Leslie's total buy and sell value in the current window?
Inside the rolling retention window, Trigg Leslie bought $0 and sold $122K based on SEC Form 4 filings.
What was Trigg Leslie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,794 OM shares on 2026-01-20, worth $60K, per SEC Form 4 filings.